|
1
|
Ward E, DeSantis C, Robbins A, Kohler B
and Jemal A: Childhood and adolescent cancer statistics, 2014. CA
Cancer J Clin. 64:83–103. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Choi DK and Schmidt ML: Chemotherapy in
children with head and neck cancers: Perspectives and review of
current therapies. Oral Maxillofacial Surg Clin N Am. 28:127–138.
2016. View Article : Google Scholar
|
|
3
|
Marcus KJ and Tishler RB: Head and neck
carcinomas across the age spectrum: Epidemiology, therapy, and late
effects. Semin Radiat Oncol. 20:52–57. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang Y, Lipari P, Wang X, Hailey J, Liang
L, Ramos R, Liu M, Pachter JA, Bishop WR and Wang Y: A fully human
insulin-like growth factor-I receptor antibody SCH 717454
(Robatumumab) has antitumor activity as a single agent and in
combination with cytotoxics in pediatric tumor xenografts. Mol
Cancer Ther. 9:410–418. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Morrison R, Gardiner C, Evidente A, Kiss R
and Townley H: Incorporation of ophiobolin a into novel
chemoembolization particles for cancer cell treatment. Pharm Res.
31:2904–2917. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xie M, Zhang H, Xu Y, Liu T, Chen S, Wang
J and Zhang T: Expression of folate receptors in nasopharyngeal and
laryngeal carcinoma and folate receptor-mediated endocytosis by
molecular targeted nanomedicine. Int J Nanomed. 8:2443–2451. 2013.
View Article : Google Scholar
|
|
7
|
Chen Y, Xu G, Zheng Y, Yan M, Li Z, Zhou
Y, Mei L and Li X: Nanoformulation of D-α-tocopheryl polyethylene
glycol 1000 succinate-b-poly(ε-caprolactone-ran-glycolide) diblock
copolymer for siRNA targeting HIF-1α for nasopharyngeal carcinoma
therapy. Int J Nanomed. 10:1375–1386. 2015.
|
|
8
|
Koganti S, Jagani HV, Palanimuthu VR,
Mathew JA, Rao MC and Rao JV: In vitro and in vivo evaluation of
the efficacy of nanoformulation of siRNA as an adjuvant to improve
the anticancer potential of cisplatin. Exp Mol Pathol. 94:137–147.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Oberoi HS, Nukolova NV, Kabanov AV and
Bronich TK: Nanocarriers for delivery of platinum anticancer drugs.
Adv Drug Deliv Rev. 65:1667–1685. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kojima H, Iida M, Yaguchi Y, Suzuki R,
Hayashi N, Moriyama H and Manome Y: Enhancement of cisplatin
sensitivity in squamous cell carcinoma of the head and neck
transfected with a survivin antisense gene. Arch Otolaryngol Head
Neck Surg. 132:682–685. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jiang M, Liu Z, Xiang Y, Ma H, Liu S, Liu
Y and Zheng D: Synergistic antitumor effect of AAV-mediated TRAIL
expression combined with cisplatin on head and neck squamous cell
carcinoma. BMC Cancer. 11:542011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shao Z, Shao J, Tan B, Guan S, Liu Z, Zhao
Z, He F and Zhao J: Targeted lung cancer therapy: Preparation and
optimization of transferrin-decorated nanostructured lipid carriers
as novel nanomedicine for co-delivery of anticancer drugs and DNA.
Int J Nanomed. 10:1223–1233. 2015. View Article : Google Scholar
|
|
13
|
Teo PY, Cheng W, Hedrick JL and Yang YY:
Co-delivery of drugs and plasmid DNA for cancer therapy. Adv Drug
Deliv Rev. 98:41–63. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang T, Zhao P, Rong Z, Li B, Xue H, You
J, He C, Li W, He X, Lee RJ, et al: Anti-tumor efficiency of
lipid-coated cisplatin nanoparticles co-loaded with microRNA-375.
Theranostics. 6:142–154. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wasungu L and Hoekstra D: Cationic lipids,
lipoplexes and intracellular delivery of genes. J Control Release.
116:255–264. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang L, Chan JM, Gu FX, Rhee JW, Wang AZ,
Radovic-Moreno AF, Alexis F, Langer R and Farokhzad OC:
Self-assembled lipid - polymer hybrid nanoparticles: A robust drug
delivery platform. ACS Nano. 2:1696–1702. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang XZ, Dou S, Wang YC, Long HY, Xiong
MH, Mao CQ, Yao YD and Wang J: Single-step assembly of cationic
lipid-polymer hybrid nanoparticles for systemic delivery of siRNA.
ACS Nano. 6:4955–4965. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bose RJ, Arai Y, Ahn JC, Park H and Lee
SH: Influence of cationic lipid concentration on properties of
lipid-polymer hybrid nanospheres for gene delivery. Int J Nanomed.
10:5367–5382. 2015.
|
|
19
|
He C, Lu J and Lin W: Hybrid nanoparticles
for combination therapy of cancer. J Control Release. 219:224–236.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hadinoto K, Sundaresan A and Cheow WS:
Lipid-polymer hybrid nanoparticles as a new generation therapeutic
delivery platform: A review. Eur J Pharm Biopharm. 85(3 Pt A):
427–443. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Guo S, Wang Y, Miao L, Xu Z, Lin CM, Zhang
Y and Huang L: Lipid-coated Cisplatin nanoparticles induce
neighboring effect and exhibit enhanced anticancer efficacy. ACS
Nano. 7:9896–9904. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Han L, Ren Y, Long L, Zhong Y, Shen C, Pu
P, Yuan X and Kang C: Inhibition of C6 glioma in vivo by
combination chemotherapy of implantation of polymer wafer and
intracarotid perfusion of transferrin-decorated nanoparticles.
Oncol Rep. 27:121–128. 2012.PubMed/NCBI
|
|
23
|
Nakata H, Miyazaki T, Iwasaki T, Nakamura
A, Kidani T, Sakayama K, Masumoto J and Miura H: Development of
tumor-specific caffeine-potentiated chemotherapy using a novel drug
delivery system with Span 80 nano-vesicles. Oncol Rep.
33:1593–1598. 2015.PubMed/NCBI
|
|
24
|
Yu W, Liu C, Ye J, Zou W, Zhang N and Xu
W: Novel cationic SLN containing a synthesized single-tailed lipid
as a modifier for gene delivery. Nanotechnology. 20:2151022009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang RH, Cao HM, Tian ZJ, Jin B, Wang Q,
Ma H and Wu J: Efficacy of dual-functional liposomes containing
paclitaxel for treatment of lung cancer. Oncol Rep. 33:783–791.
2015.PubMed/NCBI
|
|
26
|
Yu W, Liu C, Liu Y, Zhang N and Xu W:
Mannan-modified solid lipid nanoparticles for targeted gene
delivery to alveolar macrophages. Pharm Res. 27:1584–1596. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang Q, Zhang S, Kang M, Dong R and Zhao
J: Synergistic growth inhibition by sorafenib and cisplatin in
human osteosarcoma cells. Oncol Rep. 33:2537–2544. 2015.PubMed/NCBI
|
|
28
|
Almeida PV, Shahbazi MA, Mäkilä E,
Kaasalainen M, Salonen J, Hirvonen J and Santos HA: Amine-modified
hyaluronic acid-functionalized porous silicon nanoparticles for
targeting breast cancer tumors. Nanoscale. 6:10377–10387. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ye Y, Zhang X, Zhang T, Wang H and Wu B:
Design and evaluation of injectable niclosamide nanocrystals
prepared by wet media milling technique. Drug Dev Ind Pharm.
41:1416–1424. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gao L, Xu Z, Wang Y, Sun B, Song Z, Yang
B, Liu X, Lin Y, Peng J, Han G, et al: Anticancer effect of SZC017,
a novel derivative of oleanolic acid, on human gastric cancer
cells. Oncol Rep. 35:1101–1108. 2016.PubMed/NCBI
|
|
31
|
Lv X, Liu F, Shang Y and Chen SZ: Honokiol
exhibits enhanced antitumor effects with chloroquine by inducing
cell death and inhibiting autophagy in human non-small cell lung
cancer cells. Oncol Rep. 34:1289–1300. 2015.PubMed/NCBI
|
|
32
|
Mainardes RM and Evangelista RC: PLGA
nanoparticles containing praziquantel: Effect of formulation
variables on size distribution. Int J Pharm. 290:137–144. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu P, Sun L, Zhou DS, Zhang P, Wang YH,
Li D, Li QH and Feng RJ: Development of alendronate-conjugated poly
(lactic-co-glycolic acid)-dextran nanoparticles for active
targeting of cisplatin in osteosarcoma. Sci Rep. 5:173872015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Asthana S, Jaiswal AK, Gupta PK, Dube A
and Chourasia MK: Th-1 biased immunomodulation and synergistic
antileishmanial activity of stable cationic lipid-polymer hybrid
nanoparticle: Biodistribution and toxicity assessment of
encapsulated amphotericin B. Eur J Pharm Biopharm. 89:62–73. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Valencia PM, Basto PA, Zhang L, Rhee M,
Langer R, Farokhzad OC and Karnik R: Single-step assembly of
homogenous lipid-polymeric and lipid-quantum dot nanoparticles
enabled by microfluidic rapid mixing. ACS Nano. 4:1671–1679. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Seedat N, Kalhapure RS, Mocktar C, Vepuri
S, Jadhav M, Soliman M and Govender T: Co-encapsulation of
multi-lipids and polymers enhances the performance of vancomycin in
lipid-polymer hybrid nanoparticles: In vitro and in silico studies.
Mater Sci Eng C. 61:616–630. 2016. View Article : Google Scholar
|
|
37
|
D'Mello S, Salem AK, Hong L and Elangovan
S: Characterization and evaluation of the efficacy of cationic
complex mediated plasmid DNA delivery in human embryonic palatal
mesenchyme cells. J Tissue Eng Regen Med. 10:927–937. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dong W, Jin GH, Li SF, Sun QM, Ma DY and
Hua ZC: Cross-linked polyethylenimine as potential DNA vector for
gene delivery with high efficiency and low cytotoxicity. Acta
Biochim Biophys Sin (Shanghai). 38:780–787. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Khurana B, Goyal AK, Budhiraja A, Aora D
and Vyas SP: Lipoplexes versus nanoparticles: pDNA/siRNA delivery.
Drug Deliv. 20:57–64. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Krishnamurthy S, Vaiyapuri R, Zhang L and
Chan JM: Lipid-coated polymeric nanoparticles for cancer drug
delivery. Biomater Sci. 3:923–936. 2015. View Article : Google Scholar : PubMed/NCBI
|
